scholarly journals Electrophysiological Characteristics of Embryonic Stem Cell-Derived Cardiomyocytes are Cell Line-Dependent

2015 ◽  
Vol 35 (1) ◽  
pp. 305-314 ◽  
Author(s):  
Tobias Hannes ◽  
Marie Wolff ◽  
Michael Xavier Doss ◽  
Kurt Pfannkuche ◽  
Moritz Haustein ◽  
...  

Background: Modelling of cardiac development, physiology and pharmacology by differentiation of embryonic stem cells (ESCs) requires comparability of cardiac differentiation between different ESC lines. To investigate whether the outcome of cardiac differentiation is consistent between different ESC lines, we compared electrophysiological properties of ESC-derived cardiomyocytes (ESC-CMs) of different murine ESC lines. Methods: Two wild-type (D3 and R1) and two transgenic ESC lines (D3/aPIG44 and CGR8/AMPIGX-7) were differentiated under identical culture conditions. The transgenic cell lines expressed enhanced green fluorescent protein (eGFP) and puromycin-N-acetyltransferase under control of the cardiac specific α-myosin heavy chain (αMHC) promoter. Action potentials (APs) were recorded using sharp electrodes and multielectrode arrays in beating clusters of ESC-CMs. Results: Spontaneous AP frequency and AP duration (APD) as well as maximal upstroke velocity differed markedly between unpurified CMs of the four ESC lines. APD heterogeneity was negligible in D3/aPIG44, moderate in D3 and R1 and extensive in CGR8/AMPIGX-7. Interspike intervals calculated from long-term recordings showed a high degree of variability within and between recordings in CGR8/AMPIGX-7, but not in D3/aPIG44. Purification of the αMHC+ population by puromycin treatment posed only minor changes to APD in D3/aPIG44, but significantly shortened APD in CGR8/AMPIGX-7. Conclusion: Electrophysiological properties of ESC-CMs are strongly cell line-dependent and can be influenced by purification of cardiomyocytes by antibiotic selection. Thus, conclusions on cardiac development, physiology and pharmacology derived from single stem cell lines have to be interpreted carefully.

Stem Cells ◽  
2008 ◽  
Vol 26 (6) ◽  
pp. 1444-1453 ◽  
Author(s):  
Florence Wianny ◽  
Agnieszka Bernat ◽  
Cyril Huissoud ◽  
Guillaume Marcy ◽  
Suzy Markossian ◽  
...  

2006 ◽  
Vol 102 (1) ◽  
pp. 14-20 ◽  
Author(s):  
Shigehiko Ueda ◽  
Masahide Yoshikawa ◽  
Yukiteru Ouji ◽  
Ko Saito ◽  
Kei Moriya ◽  
...  

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 4232-4232
Author(s):  
C. Anthony Blau ◽  
Angelique Nelson ◽  
Carol B. Ware

Abstract In October 2003, the National Institutes of Health (NIH) established three extramural “Exploratory Centers for Human Embryonic Stem Cell Research.” Our Center’s experience in acquiring and manipulating NIH-approved human embryonic stem (hES) cell lines may be useful for other institutions interested in pursuing NIH-funded hES cell research. We acquired 14 of the 22 NIH-approved cell lines. Modifications to the proposed Material Transfer Agreements (MTAs) with hES cell suppliers were sought to improve accessibility to these hES cell lines by local researchers. Lines were characterized for survival following cryopreservation and for their ability to adapt to a uniform set of culture conditions while maintaining a normal karyotype. Each of the 4 suppliers contacted eventually agreed to terms that improved access to their hES cell lines. Eleven hES cell lines were received frozen, and in 10 cases very few cells survived cryopreservation. Ten hES cell lines were successfully converted to simplified culture conditions that enhanced their ability to be maintained and expanded in culture. One hES cell line had an unstable karyotype at an early passage. Current MTA provisions continue to present significant obstacles to NIH-funded hES cell research. Many hES cell lines can be maintained using culture conditions less onerous than those recommended by their suppliers.


2010 ◽  
Vol 6 (3) ◽  
pp. 462-472 ◽  
Author(s):  
Miguel Angel Blanco-Gelaz ◽  
Beatriz Suarez-Alvarez ◽  
Gertrudis Ligero ◽  
Laura Sanchez ◽  
Jose Ramon Vidal-Castiñeira ◽  
...  

2006 ◽  
Vol 8 (4) ◽  
pp. 319-334 ◽  
Author(s):  
Judy M. Fletcher ◽  
Patricia M. Ferrier ◽  
John O. Gardner ◽  
Linda Harkness ◽  
Seema Dhanjal ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document